In human glioblastoma, IL-6 levels are endogenously lower in patients who achieve histological or radiographic responses to ICI, and ICI-resistant glioblastoma has elevated stem cell markers (SOX2, SOX4, SOX13, PTPRZ1), which can be driven by IL-621,58. This evidence concerns the gene SOX2 and glioblastoma.